Growth Metrics

Bruker (BRKR) EBITDA Margin (2016 - 2025)

Bruker (BRKR) has disclosed EBITDA Margin for 16 consecutive years, with 1.3% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 606.0% year-over-year to 1.3%, compared with a TTM value of 0.13% through Dec 2025, down 738.0%, and an annual FY2025 reading of 0.13%, down 738.0% over the prior year.
  • EBITDA Margin was 1.3% for Q4 2025 at Bruker, up from 6.02% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 18.49% in Q4 2022 and bottomed at 6.02% in Q3 2025.
  • Average EBITDA Margin over 5 years is 7.68%, with a median of 7.84% recorded in 2023.
  • The sharpest move saw EBITDA Margin soared 670bps in 2022, then tumbled -1390bps in 2025.
  • Year by year, EBITDA Margin stood at 11.79% in 2021, then skyrocketed by 57bps to 18.49% in 2022, then crashed by -35bps to 12.11% in 2023, then tumbled by -39bps to 7.36% in 2024, then plummeted by -82bps to 1.3% in 2025.
  • Business Quant data shows EBITDA Margin for BRKR at 1.3% in Q4 2025, 6.02% in Q3 2025, and 1.49% in Q2 2025.